NSCLC In A Nutshell

Maintenance therapy with ICIs (atezolizumab or durvalumab) is already established in extensive stage small-cell lung cancer, but lurbinectedin enters the chat with a recent FDA approval. Next up - tarlatamab? IMforte (maintenance lurbinectedin + atezolizumab): https://doi.org/10. ... Show More

Our Landmarks of OncoPharm series returns to discuss PARAMOUNT, a landmark study that helped solidify the role of maintenance pemetrexed in NSCLC. 

The long awaited subcutaneous formulation of pembrolizumab is not FDA-approved. We discuss its administration and toxicity & PK differences vs. IV use. Biotin supplementation can interfere with lots of labs cancer patients get routinely - Who knew? (Ahem, not me.) Link: https://d ... Show More

Let's preview the show! Should be super exciting!  

Here's some GOOD NEWS! 

What’s hotter than a fresh-off-the-press book in your hands? Knowing exactly what’s going to blow your mind before it even drops. This week, Mikayla, Reggie, and Kennedy spill the tea on their most anticipated reads of 2025. From jaw-dropping plot twists to characters we’re alrea ... Show More

finally launching Huda Hotline  

Today's installment is a repost of a mix from 10 years ago looking at the best of 2015 

In this episode, we're reacting to the community’s picks for which artists might drop the best album of the year in 2025. We also discuss our contenders, our power rankings and more. Some of the albums discussed include Hurry Up Tomorrow by The Weeknd, The Fall Off by J. Cole, JI ... Show More

Season Two of playing god? is coming soon. Here's a preview of what's in the works. 

Preview of upcoming content. 

the long awaited return! 

I’m so excited